Ovarian cancer is the most lethal gynecological malignancy. Poor overall survival,
particularly for patients with high grade serous (HGS) ovarian cancer, is often attributed to …

Simple Summary This manuscript focuses on cancer stem cells and the diagnostic potential
of selected biomarkers of these cells in ovarian cancers. Ovarian cancer has nonspecific …

TWIST protein is critical to development and is activated in many cancers. TWIST regulates
epithelial-mesenchymal transition, and is linked to angiogenesis, metastasis, cancer stem …

Ovarian cancer (OC) lacks effective biomarkers for diagnosis at an early stage and often
develops chemoresistance after the initial treatment at an advanced stage. RNA‑binding …

Epithelial ovarian cancer (EOC) is the most deadly gynecologic malignancy on account of its
late stage at diagnosis and frequency of drug resistant recurrences. Novel therapies to …

Objectives: CD44, a transmembrane glycoprotein, is involved in the generation of a stem cell
niche and maintaining stem cell quiescence. The aim of this study was to evaluate its …

Abstract Background/Aims: Relevant markers of cancer stem cells (CSCs) may serve as
commonly used biomarkers of ovarian cancer (OC). However, their actual …

Ovarian Cancer is the fifth most common cancer in females and remains the most lethal
gynecological malignancy as most patients are diagnosed at late stages of the disease …

The aim of our study was to clarify whether the CD44 adhesion molecule as a cancer stem
cell marker could also serve as a prognostic factor in patients with epithelial ovarian cancer …

CD44 is a prognostic indicator of shorter survival time in ovarian cancer. E‑cadherin
fragmentation promotes the progression of ovarian cancer. However, the effects of CD44 …